IN8BIO INC reports a Return on Equity (ROE) of -83.32%.

What is INAB's dividend yield?

IN8BIO INC offers a dividend yield of 0.00%.

What is INAB's Deepscope Quality Score?

Deepscope rates INAB's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy INAB?

Deepscope's AI Timing Score for INAB is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does INAB belong to?

IN8BIO INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu INAB (NASDAQ) | IN8BIO INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-12 | FS: 2026-03-31)

INAB

IN8BIO INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 87

USD 1.43

-0.01 (-0.69%) Day Change

Watchlist Portfolio Compare Chart

0.05

D/E

-83.3%

ROE

-72.3%

ROA

0.00%

Div Yield

IN8BIO INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 1.43 Price -0.01 (-0.69%) Day Change	NEWS SCORE: 87

INAB Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 23) và Thời điểm mua ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	87
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.43
PBV / Sector	0.61 / 4.91 GREAT
Earning Per Share	-1.97

PE / Sector	N/A / 18.34
PEG or PE/Growth / Sector	N/A / 0.61
Average 1M Daily Value	0.12 M GREAT
Average 1W Daily Value	0.05 M GREAT

Yếu tố Kỹ thuật

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 468.85
NPM Average (%) / Sector	N/A / -1,531.69
NPM Change Average (%) / Sector	N/A / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-72.26 / 31.69
ROA Average (%) / Sector	-89.96 / -353.18
ROA Change Average (%) / Sector	7.99 / 5,214.65
ROE (%) / Sector	-83.32 / 10.58
ROE Average (%) / Sector	-121.01 / 27.64
ROE Change Average (%) / Sector	6.53 / 2,048.88
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.15

Chi tiết đăng ký

Analyze Date	2026-06-13 11:13:00
Symbol	INAB
Name	IN8BIO INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	9.59 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	13.81 / 9,034.83

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 350 5th Avenue, New York, NY, United States, 10118

Phone: 646 600 6438

Website: https://in8bio.com

Sector: Healthcare >> Biotechnology

Description: IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its lead product candidates include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company also develops INB-619, a gamma-delta TCE targeting CD19 for both oncology and autoimmune diseases; INB-300, a nsCAR-enabled DeltEx product candidates targeting difficult liquid tumors and extracranial solid tumors; INB-500, an induced pluripotent stem cell derived gamma-delta T cells that are in preclinical phase for treatment of cancer; and INB-600, a gamma-Delta T cell engager. In addition, it is developing INB-619, a gamma-delta TCE targeting CD19 for potential applications in both oncology and autoimmune diseases. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.